AI Article Synopsis

  • The study assessed the mental health impacts, specifically PTSD, depression, anxiety, and insomnia, in patients with Marfan syndrome during the COVID-19 pandemic in Lombardy, Italy.
  • Approximately 10% of the 112 participants demonstrated concerning psychological symptoms, with PTSD primarily linked to higher anxiety levels, older age, use of psychoactive medications, and unemployment.
  • The findings highlight the need for ongoing mental health monitoring and the development of targeted psychosocial interventions for Marfan syndrome patients to address mental health challenges exacerbated by the pandemic.

Article Abstract

Objective: The evaluation of post-traumatic stress disorder (PTSD), depression, anxiety and insomnia in patients with Marfan syndrome (MFS) during the third wave of the COVID-19 pandemic in a region of northern Italy (Lombardy) and the investigation of which mental health, sociodemographic and clinical factors were associated with PTSD.

Design: Descriptive observational design with cross-sectional data collection procedure.

Setting: A single Italian MFS-specific specialised and reference centre in Lombardy (Italy) between February and April 2021.

Participants: 112 adults with MFS. The majority of participants were female (n=64; 57.1%), with a high school diploma (n=52; 46.4%) and active workers (n=66; 58.9%). The mean age was 41.89 years (SD=14.00), and the mean time from diagnosis was 15.18 years (SD=11.91).

Primary And Secondary Outcomes: Descriptive statistics described PTSD, which was the primary outcome, as well as depression, anxiety and insomnia, which were the secondary outcomes. Four linear regression models described the predictors of PTSD total score and its three domains: avoidance, intrusion and hyperarousal.

Results: One out of 10 patients with MFS had mild psychological symptoms regarding depression, anxiety and insomnia, and scores of PTSD that indicated clinical worries about the mental health status. The presence of PTSD was mainly predicted by anxiety (β=0.647; p<0.001), being older, taking psychoactive medication and being unemployed.

Conclusion: Depression, anxiety and insomnia should be monitored in patients with MFS in order to minimise PTSD insurgence. Specific psychosocial interventions should be developed and tested for this population and adopted in clinical practice, given the relevance of mental health outcomes during the pandemic.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748516PMC
http://dx.doi.org/10.1136/bmjopen-2022-067024DOI Listing

Publication Analysis

Top Keywords

depression anxiety
16
anxiety insomnia
16
post-traumatic stress
8
stress disorder
8
marfan syndrome
8
third wave
8
mental health
8
secondary outcomes
8
anxiety
5
ptsd
5

Similar Publications

Background: Barriers to mental health assessment and intervention have been well documented within South Africa, in both urban and rural settings. Internationally, evidence has emerged for the effectiveness of technology and, specifically, app-based mental health tools and interventions to help overcome some of these barriers. However, research on digital interventions specific to the South African context and mental health is limited.

View Article and Find Full Text PDF

While social support benefits those in treatment for opioid use disorder, it is unclear how social support impacts patient outcomes. This study examines how support person attitudes toward buprenorphine and their communication about substance use are associated with the well-being of patients receiving buprenorphine treatment. We analyzed cross-sectional baseline data from 219 buprenorphine patients (40% female) and their support persons (72% female).

View Article and Find Full Text PDF

Background: Psychological distress, such as depression and anxiety, impacts cardiovascular disease (CVD) prognosis and management. Illness comprehension is essential for effective treatment, but biases can lead to suboptimal outcomes. We explored psycho-cardiovascular disease (PCD) patient characteristics, with a specific focus on comprehension biases and treatment choices from patients' perspectives in China, to improve management strategies.

View Article and Find Full Text PDF

Impact of Sensitive Skin on Quality of Life, Anxiety, and Depression: A Cross-Sectional Study.

Clin Exp Dermatol

January 2025

Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

Background: Sensitive skin (SS) is a common condition reported by many people worldwide. Patient interviews reveal that individuals with SS experience diminished quality of life, anxiety, and depression. Nonetheless, the impact of SS on mental health remains unclear.

View Article and Find Full Text PDF

Background: Non-motor symptoms, including depression, anxiety, sleep disturbances, pain and cognitive dysfunction, are a much more important predictor of quality of life than the severity of dystonia.

Objectives: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia.

Methods: Patients aged > 18 years diagnosed with idiopathic focal dystonia were recruited in this longitudinal cohort study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!